Navigation Links
Covance To Present At The William Blair 32nd Annual Growth Stock Conference

PRINCETON, N.J., June 8, 2012 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the William Blair 32nd Annual Growth Stock Conference on Tuesday, June 12, 2012 at 9:50 a.m. (ET).  Investors may access a live webcast of the presentation at  In order to register and download any necessary software, please log on 10 minutes early.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $2 billion, global operations in more than 30 countries, and more than 11,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at

Statements contained in this press release (and in the webcast announced in this press release), which are not historical facts, such as statements about prospective earnings, savings, revenue, operations, revenue, earnings growth, and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including the statements contained herein regarding anticipated trends in the Company's business are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, levels of industry research and development spending, the Company's ability to continue to attract and retain qualified personnel, the fixed price nature of contracts or the loss or delay of large studies, risks associated with acquisitions and investments, the Company's ability to increase order volume, the pace of translation of orders into revenue in late-stage development services, testing mix and geographic mix of kit receipts in central laboratories, fluctuations in currency exchange rates, and other factors described in the Company's filings with the Securities and Exchange Commission including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no duty to update any forward looking statement to conform the statement to actual results or changes in the Company's expectations.

SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Company To Present At The William Blair Growth Stock Conference
2. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
3. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
4. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
5. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
6. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
7. Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting
8. Regeneron Announces June 2012 Investor Conference Presentations
9. Isis Pharmaceuticals to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference
10. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
11. Vanda Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference
Post Your Comments:
(Date:10/12/2015)... , October 12, 2015 ... research report "Spirometer Market by Product (Hand-held, Table-top, Desktop), Technology ... Homecare), Application, & Geography - Global Forecast to 2020", published ... 858.6 Million by 2020, at a CAGR of 9.8% from ... and 128 F igures spread th rough 187 ...
(Date:10/12/2015)... PUNE, India , October 12, 2015 /PRNewswire/ ... The Plague - Pipeline Review, H2 2015 ... helps strengthen plague R&D pipelines by identifying new ... products. . --> ... report on Plague pipeline spread across 62 pages, ...
(Date:10/12/2015)... 2015 Device usage in healthcare continues to ... these devices into existing clinical workflow. In response, Ergotron, ... mobility solutions, has launched the SV10 series of its ... wide array of laptops and tablets. In addition, one ... for Microsoft Surface and is compatible with all Surface ...
Breaking Medicine Technology:
(Date:10/12/2015)... ... October 12, 2015 , ... The Horizon Foundation for ... focused on improving public health and enhancing the quality of life in the Garden ... 11 New Jersey non-profit organizations. , The charitable arm of Horizon Blue Cross ...
(Date:10/12/2015)... ... October 12, 2015 , ... ... present the latest version of Companion Mics, the CM•4 Multi-Talker Noise Reduction System, ... Union of Hearing Aid Acousticians’ (EUHA) 60th Annual Congress in Nuremberg, Germany. ...
(Date:10/12/2015)... Town, Maine (PRWEB) , ... October 12, 2015 , ... ... Lake Itasca, MN. Their mission: To paddle the entire 2,320-miles of river to the ... are now halfway done with the monumental journey, with two months remaining for a ...
(Date:10/12/2015)... (PRWEB) , ... October 12, 2015 , ... ... to be a part of a contact channel benchmarking study. Be ... comparisons of key operational strategies for improving customer experience, customer journey, contact channel ...
(Date:10/12/2015)... Colorado Springs, CO (PRWEB) , ... October 12, 2015 , ... NFL football fans who ... to consider donating to a great cause. CLICK HERE to donate to Smile ... and receive an opportunity to win an all-inclusive trip to the 2016 NFL Super Bowl! ...
Breaking Medicine News(10 mins):